Prostate cancer
Prostate cancer treatment: minimally invasive options
A prostate cancer diagnosis does not automatically lead to removing the gland. Depending on the aggressiveness of the tumor and its extent, several strategies are discussed—including focal treatments, which target the affected area rather than the entire prostate.
A diagnosis does not mean surgery
This is the first point to establish. The prostate cancer evolves most often slowly, and not all of its forms require the same treatment. Certain cancers, which are not very aggressive, warrant simple close monitoring; others require prompt management.
What distinguishes these situations is neither the PSA level alone, nor the age: it is the tumor grade, established by the analysis of prostate biopsies and expressed by the Gleason score, translated into ISUP prognostic groups from 1 to 5.
Five strategies can be discussed:
- Active surveillance close monitoring of PSA, MRI, and biopsies, without immediate treatment, for low-aggressiveness forms
- Surgery — radical prostatectomy, complete removal of the gland
- Radiotherapy — external or by brachytherapy
- Focal treatments - cryotherapy or focused ultrasound, targeting the tumor area alone
- Drug treatments - hormone therapy, in certain situations or in combination
A useful clarification
L'prostatic artery embolization It does not treat cancer. It addresses the symptoms of'benign hypertrophy. Both conditions can coexist, but they are treated separately.
Comparison of strategies
When treatment is indicated, three paths are discussed. None is superior on all criteria: here is what each provides, and what it costs.
| Criterion | Surgery | Radiotherapy | Focal treatment |
|---|---|---|---|
| Target | Entire gland | Entire gland | Tumor zone |
| Anesthesia | General | None | General or local |
| Hospitalization | Several days | Outpatient sessions | Often outpatient |
| Urinary continence | Risk of incontinence | Risk of urinary disorders | Most often preserved |
| Erectile function | High risk of alteration | Possible and delayed alteration | Most often preserved |
| Scientific setback | Standard of care | Standard of care | Less established in the long term |
| Main limit | Functional impact | Late effects, difficult-to-interpret PSA | Strict selection, necessary monitoring |
Data from international literature. Each indication is individual and is decided upon through multidisciplinary consultation.
The principle of focal treatment
Definition
A focal treatment destroys the tumor zone identified on the MRI and confirmed by biopsies, while seeking to spare the rest of the gland and neighboring structures: urinary sphincter, erection nerve bundles, rectum.
The logic therefore differs radically from that of whole-gland treatments. Where surgery and radiotherapy treat the entire prostate to be certain of covering the tumor, the focal approach agrees to target it, at the price of one requirement: knowing exactly where the cancer is located.
This explains why this approach was only possible from the moment when'multiparametric MRI and targeted biopsies made it possible to precisely map the disease. Inaccurate mapping would render focal treatment illusory.
Two techniques, one goal
The cryotherapy destroys tissue by cold, the high-intensity focused ultrasound by heat. Guidance is provided by imaging, without an incision.
In both cases, the objective is identical: to control the cancer while limiting the impact on continence and sexuality.
Focal cryotherapy of the prostate
The cryotherapy, or cryoablation, consists of freezing the tumor tissue using probes inserted transperineally under ultrasound guidance. The controlled cooling causes ice crystals to form inside the cells, leading to their destruction.
The course of the intervention
- Initial assessmentMultiparametric MRI and targeted biopsies, which precisely locate the lesion and confirm its grade. Without this mapping, focal therapy cannot be considered.
- Installation of the probesUnder anesthesia, cryogenic probes are positioned transperineally, under ultrasound guidance, into the area to be treated.
- Freezing cyclesControlled freezing and thawing cycles are applied. The temperature and the expansion of the ice ball are monitored in real time.
- SuitesThe procedure is most often performed on an outpatient basis or with a short hospital stay. A urinary catheter is usually left in place for a few days.
What cryotherapy provides
- A targeted approach, which spares the rest of the gland and functional structures
- A minimally invasive procedure, without incision, often performed on an outpatient basis
- Faster recovery than that of resection surgery
- A functional preservation most often obtained, regarding both continence and erection
- An option for fragile patients, for whom major surgery would be risky
- A repeatable treatment and not ruling out subsequent catch-up treatment
What you need to know before choosing
- The long-term decline remains limited compared to surgery and radiotherapy, whose oncological outcomes have been documented for decades
- Patient selection is strict not all cancers are suitable, particularly multifocal, extensive, or high-grade forms
- Close monitoring remains essential after treatment, because the preserved gland may harbor other foci
- Complications are possible : urinary disorders transient, infection, bleeding, more rarely fistula
Does your case involve focal treatment?
Send your biopsy report, your MRI, and your latest PSA. We will let you know if this option can be discussed in your case.
HIFU: Focused Ultrasound
The HIFU, for High Intensity Focused Ultrasound, relies on the opposite principle of cryotherapy: it destroys tissue through heat. High-intensity ultrasound waves are focused on a precise point in the gland, where they cause a highly localized rise in temperature.
The probe is introduced rectally and the treatment is image-guided. As with cryotherapy, the procedure does not require any incisions and can often be performed in ambulatory.
Both techniques share the same indications, limitations, and level of evidence. The choice between them depends mainly on the location of the lesion within the gland, its volume, and the patient's anatomy. In practice, this decision is up to the team taking care of you, after a complete review of your file.
For which patients?
Focal therapy is intended for a specific population. Selecting it correctly determines its value.
It is argued in principle before:
- A localized cancer, without extension beyond the gland
- A single or dominant lesion, well identified on the MRI and confirmed by the biopsies
- A intermediate or low grade, typically ISUP 1 to 2, sometimes 3 depending on the situation
- A patient informed of the uncertainties and accepting close monitoring
Conversely, it is not suitable for multifocal cancers disseminated throughout the gland, high-grade forms, tumors extending beyond the capsule, or locations that make targeting difficult.
Let us finally clarify what focal therapy is not: it is neither a comfort treatment nor a default option to avoid surgery. It is a strategy in its own right, with its own follow-up requirements.
What the recommendations say
Current position
The 2026 European guidelines consider that HIFU and focal cryotherapy must be performed as part of a prospective registry. In other words, these techniques are recognized and practiced, but their long-term results continue to be evaluated.
This nuance deserves to be understood rather than passed over in silence. It does not mean that these treatments are experimental or risky: it means that the medical community continues to measure their oncological effectiveness over the long term, whereas surgery and radiotherapy have several decades of hindsight.
For you, this translates into two concrete requirements: one complete information before deciding, and a organized follow-up after treatment. Preserving quality of life as much as possible must never come at the expense of cancer control.
Frequently asked questions
Can prostate cancer be treated without removing the prostate?
Yes, in selected patients with localized cancer. Focal treatment with cryotherapy or HIFU targets the tumor area while preserving the rest of the gland. This is not a suitable alternative for all cancers, and the information must include the uncertainties regarding long-term outcomes.
Does focal therapy preserve erection?
This is its goal, and it is most often achieved: by sparing the nerve bundles located on either side of the prostate, the technique limits the impact on sexual function. The result depends, however, on the location of the lesion and erectile function prior to treatment.
What happens if the cancer recurs?
Focal treatment does not exclude any subsequent options. A new focal session, salvage surgery or salvage radiotherapy remain possible. This is, in fact, one of the arguments in favor of this approach in well-selected patients.
Is general anesthesia required?
This depends on the technique, the volume to be treated, and your profile. Cryotherapy is performed under general or local anesthesia depending on the case. This point is specified during the preliminary consultation.
How is post-treatment follow-up organized?
It relies on regular PSA testing, a follow-up MRI, and, depending on the situation, new biopsies. This monitoring is inseparable from focal therapy: since the gland is preserved, it must continue to be monitored.
Can I get a second opinion before deciding?
It is even recommended. We regularly review the medical records of patients who have received a treatment proposal elsewhere so that they can compare their options before making a decision. Patients coming from abroad can have their application reviewed remotely.
Have your file proofread
Send your biopsy report with the Gleason score, your prostate MRI and your latest PSA levels. We will let you know which options can be discussed in your situation.
Prostate Center — Blomet Clinic
136 bis rue Blomet, 75015 Paris · Monday to Saturday, 9 AM – 6 PM · +33 6 32 84 14 31
Related pages
Editorial responsibility. Medical content written and validated under the responsibility of Dr. Antoine Hakimé, interventional radiologist. Last medical review: September 2026. The information presented is for informational purposes and does not replace a medical consultation. No results can be guaranteed: any therapeutic indication requires an individual evaluation and is part of a shared decision, made in multidisciplinary consultation.